System combines top-down and bottom-up proteomics to improve biomarker discovery

Bio-Rad Laboratories Inc. and Bruker Corp. have jointly launched the Lucid Proteomics System, the first system to combine top-down and bottom-up proteomics approaches for biomarker discovery.
Register for free to listen to this article
Listen with Speechify
0:00
1:00
Bio-Rad Laboratories Inc. and Bruker Corp.

Bio-Rad Laboratories Inc. and Bruker Corp. have jointlylaunched the Lucid Proteomics System, the first system to combine top-down andbottom-up proteomics approaches for biomarker discovery. With both techniqueson one platform, the Lucid Proteomics System accelerates biomarker researchprograms by improving the chances of discovering biomarkers that have clinicalrelevance. The system combines Bio-Rad's ProteinChip surface-enhanced laserdesorption/ionization (SELDI)-based array technology with Bruker'sultrafleXtreme matrix-assisted laser desorption/ionization time-of-flight(MALDI-TOF/TOF) mass spectrometer. The top-down solution includeshigh-throughput protein profiling and identification of biomarker candidates,either by direct on-chip TOF/TOF analysis suitable for small peptides, or byenrichment, purification and digestion followed by TOF/TOF analysis for largerproteins. For the bottom-up approach, Bruker's ultrafleXtreme MALDI-TOF/TOFoffers unmatched performance with high sensitivity, resolution and massaccuracy. 
 
Bio-Rad Laboratories Inc.
(510) 724-7000

Bruker Corp.

(978) 663-3660
 

Related Topics

Published In

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Close-up illustration of clustered, irregularly shaped 3D cell structures resembling organoids, displayed in a blue-toned background.
Machine learning-powered image analysis makes it possible to automatically and reliably quantify complex 3D cell structures.
Illustration of a glowing human brain with interconnected neural networks and bright data points, set against a dark, digital background.
Take a closer look at modern techniques that reveal when, where, and how neurons communicate in real time.
Gloved hand holding a petri dish containing red liquid culture medium against a light blue background.
As global regulations shift toward animal-free testing, how can researchers develop more biologically relevant in vitro models to advance drug discovery?
Drug Discovery News June 2025 Issue
Latest IssueVolume 21 • Issue 2 • June 2025

June 2025

June 2025 Issue

Explore this issue